Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Oncotargets and Therapy|November 28, 2012
γ-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancerDimitrios Matthaios, Periklis G Foukas, Maria Kefala, et al.Oncogene|January 16, 2019
Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiersMaria Panagopoulou, Makrina Karaglani, Ioanna Balgkouranidou, et al.Oncology Letters|June 28, 2016
Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancerDimitrios Matthaios, Ioanna Balgkouranidou, Anastasios Karayiannakis, et al.Clinical Chemistry and Laboratory Medicine|February 14, 2013
Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survivalIoanna Balgkouranidou, Anastasios Karayiannakis, Dimitrios Matthaios, et al.Technology in Cancer Research & Treatment|April 30, 2021
Prognostic Role of RASSF1A, SOX17 and Wif-1 Promoter Methylation Status in Cell-Free DNA of Advanced Gastric Cancer PatientsEvangelos I Karamitrousis, Ioanna Balgkouranidou, Nikolaos Xenidis, et al.Biomed Research International|October 9, 2015
Overexpression of GPC6 and TMEM132D in Early Stage Ovarian Cancer Correlates with CD8+ T-Lymphocyte Infiltration and Increased Patient SurvivalAthanasios Karapetsas, Antonis Giannakakis, Denarda Dangaj, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancerNikolaos Xenidis, Michail Ignatiadis, Stella Apostolaki, et al.Frontiers in Oncology|December 23, 2024
Direct comparison of an ultrasensitive real-time PCR assay with droplet digital PCR for the detection of PIK3CA hotspot mutations in primary tumors, plasma cell-free DNA and paired CTC-derived gDNAsStavroula Smilkou, Loukas Kaklamanis, Ioanna Balgouranidou, et al.Frontiers in Pharmacology|October 2, 2023
Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in GreeceGeorgia Ragia, Anthi Maslarinou, Natalia Atzemian, et al.Journal of Cancer|April 5, 2024
Prognostic significance of BRCA1 and BRCA2 methylation status in circulating cell-free DNA of Pancreatic Cancer patientsTriantafyllia Koukaki, Ioanna Balgkouranidou, Eirini Biziota, et al.Pageof 7